title: Current management of the gastrointestinal complications of systemic sclerosis.
abstract: Systemic sclerosis is a multisystem autoimmune disorder that involves the gastrointestinal tract in more than 90% of patients. This involvement can extend from the mouth to the anus, with the oesophagus and anorectum most frequently affected. Gut complications result in a plethora of presentations that impair oral intake and faecal continence and, consequently, have an adverse effect on patient quality of life, resulting in referral to gastroenterologists. The cornerstones of gastrointestinal symptom management are to optimize symptom relief and monitor for complications, in particular anaemia and malabsorption. Early intervention in patients who develop these complications is critical to minimize disease progression and improve prognosis. In the future, enhanced therapeutic strategies should be developed, based on an ever-improving understanding of the intestinal pathophysiology of systemic sclerosis. This Review describes the most commonly occurring clinical scenarios of gastrointestinal involvement in patients with systemic sclerosis as they present to the gastroenterologist, with recommendations for the suggested assessment protocol and therapy in each situation.
authors.affiliation: Gastrointestinal Physiology Unit, University College Hospital, 235 Euston Road, London NW1 2BU, UK.
authors.forename: Anton
authors.initials: A
authors.lastname: Emmanuel
mesh_terms: D000740:Anemia / Q000209:etiology / Q000628:therapy; D001424:Bacterial Infections / Q000382:microbiology; D003680:Deglutition Disorders / Q000209:etiology / Q000628:therapy; D005242:Fecal Incontinence / Q000209:etiology / Q000628:therapy; D005544:Forecasting; D005764:Gastroesophageal Reflux / Q000209:etiology / Q000628:therapy; D005767:Gastrointestinal Diseases / Q000209:etiology / Q000628:therapy*; D000069196:Gastrointestinal Microbiome; D006801:Humans; D007421:Intestine, Small / Q000382:microbiology; D044342:Malnutrition / Q000209:etiology / Q000628:therapy; D012595:Scleroderma, Systemic / Q000150:complications*; D014839:Vomiting / Q000209:etiology / Q000628:therapy